Market Insights Health OTC Pharmaceuticals

Analgesics - United States

United States

In 2024, the revenue in the Analgesics market in the United States is estimated to reach a staggering €6.65bn.
This market is projected to experience an annual growth rate of 4.68% between 2024 and 2029, as per the compound annual growth rate (CAGR).
It is noteworthy that the in the United States generates the highest revenue globally in this market, amounting to €6.65bn in 2024.
When considering the total population, per person revenues are expected to be approximately €19.45 in 2024.
The United States has seen a surge in demand for non-opioid analgesics due to growing concerns about opioid addiction.

Key regions: Brazil, Europe, Germany, Canada, United States

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The Analgesics market in United States is experiencing steady growth driven by customer preferences, market trends, local special circumstances, and underlying macroeconomic factors.Customer preferences in the Analgesics market in United States are heavily influenced by the increasing demand for over-the-counter (OTC) pain relievers. Consumers are seeking convenient and affordable options to manage their pain, leading to a rise in the sales of OTC analgesics. Additionally, there is a growing preference for natural and herbal pain relief products, as consumers are becoming more conscious about the potential side effects of traditional analgesics.Several trends are shaping the Analgesics market in United States. One notable trend is the increasing adoption of online retail channels for purchasing analgesics. E-commerce platforms provide consumers with a wide range of options and the convenience of doorstep delivery. This trend has been further accelerated by the COVID-19 pandemic, which has led to a surge in online shopping. Another trend is the growing popularity of combination analgesics, which offer multiple active ingredients to target different types of pain. This trend caters to the diverse needs of consumers and provides them with more effective pain relief options.The Analgesics market in United States also has some local special circumstances that contribute to its development. One such circumstance is the high prevalence of chronic pain conditions among the population. Conditions such as arthritis, back pain, and migraines are common in the United States, driving the demand for analgesics. Additionally, the aging population in the country is a significant factor influencing the market. As the population ages, the incidence of chronic pain increases, leading to a higher demand for analgesics.Underlying macroeconomic factors play a crucial role in the development of the Analgesics market in United States. The country's robust healthcare infrastructure and access to advanced medical treatments contribute to the growth of the market. Moreover, the strong purchasing power of consumers enables them to afford analgesics and seek effective pain relief options. The increasing healthcare expenditure in the United States also supports the growth of the analgesics market, as consumers prioritize their health and well-being.In conclusion, the Analgesics market in United States is driven by customer preferences for OTC pain relievers and natural products, as well as trends such as the adoption of online retail channels and the popularity of combination analgesics. The local special circumstances of a high prevalence of chronic pain conditions and an aging population further contribute to the market's development. Underlying macroeconomic factors, including the robust healthcare infrastructure and strong purchasing power of consumers, also play a significant role in the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.